Does the evaluation of proliferative activity predict malignancy of prognosis in endocrine tumors?
R A
RA
DeLellis
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor / Q000032:analysis; D002455:Cell Division; D004701:Endocrine Gland Neoplasms / Q000473:pathology*; D006801:Humans; D019394:Ki-67 Antigen; D008940:Mitotic Index; D009363:Neoplasm Proteins / Q000032:analysis / Q000276:immunology; D009687:Nuclear Proteins / Q000032:analysis / Q000276:immunology; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen